StreetAlpha.app
Home › Stocks › PVLA

Palvella Therapeutics, Inc. (PVLA)

Healthcare
$142.85
▼ −2.00%
LAST CLOSE · NOV 20

Palvella Therapeutics develops topical drug candidates for rare skin diseases and vascular malformations, aimed at patients and their doctors. It last closed at $142.85 on Nov 20, down 2.00% on the day. The next earnings report for PVLA is expected around Tue, Feb 23, 2027, after the close. For the quarter ended Sep 2026, PVLA reported EPS of -$1.70. Over its last 8 reports the stock moved an average of 6.3% the session after earnings. Over the last 12 months PVLA insiders bought $850K of stock on the open market and sold $15.6M, according to SEC Form 4 filings.

AI Auto Pilots
Is PVLA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PVLA.

Key Stats

Last 12 months
Results
Net income
−$75.0M
EPS (diluted)
−$5.53
Valuation
Market cap
$2.1B
14.6M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$193.3M
At Sep 30
Shareholder equity
$197.9M
Shares outstanding
14.6M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$45.7M−$45.7MFY2021FY2022: −$33.3M−$33.3MFY2022FY2023: $18.7M$18.7MFY2023FY2024: −$17.4M−$17.4MFY2024FY2025: −$41.7M−$41.7MFY2025

From PVLA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 23
Estimated date · After the close
Reported EPS
-$1.70
Quarter ended Sep 2026
Year ago EPS
-$1.03
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.12Dec '24Mar 2025: -$0.74Mar '25Jun 2025: -$0.86Jun '25Sep 2025: -$1.03Sep '25Dec 2025: -$1.08Dec '25Mar 2026: -$1.20Mar '26Jun 2026: -$1.52Jun '26Sep 2026: -$1.70Sep '26Latest -$1.70
Revenue by quarter
Not enough quarters on file yet.
How PVLA moved after its last 8 reports
Average move the session after a report ±6.3%
Nov 5, 2026Time not announced−3.4%
Aug 4, 2026Time not announced+8.0%
May 7, 2026Time not announced−13.0%
Mar 31, 2026Time not announced+12.6%
Feb 24, 2026After the close+6.8%
Nov 10, 2025After the close−3.0%
Aug 14, 2025Time not announced+3.3%
May 15, 2025Time not announced−0.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on PVLAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on PVLA: 0 upgrades, 0 downgrades, 0 initiations
HC WainwrightReiterated
Nov 21Buy 

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on PVLA
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on PVLA

Technical Analysis

PVLA · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is 8% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 46). The nearest support is the 50 day average at $142.81, and the nearest resistance the Pivot at $144.59.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 6.2%/day
Key levels
$179.9552 week high+26.0%
$152.80Swing high (Jul 9)+7.0%
$151.7620 day average+6.2%
$146.95Pivot R1+2.9%
$145.70100 day average+2.0%
$144.59Pivot+1.2%
$142.85Last close
$142.8150 day average−0.0%
$140.54Swing low (Nov 17)−1.6%
$140.48Pivot S1−1.7%
$132.09200 day average−7.5%
$72.2252 week low−49.4%
Indicators
RSI (14)45.89Middle of its rangeNeutral
MACD1.84Below its signal lineBearish
Stochastic11.5Near the bottom of its rangeOversold
ADX (14)22.0Weak trend
Williams %R-94.1Oversold below −80, overbought above −20Oversold
CCI (20)-48.8Oversold below −100, overbought above 100Neutral
Rate of change−18.8%Change over 10 sessionsBearish
ATR (14)$8.87Typical daily range, 6.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Above
What happened before, for PVLA

What happened before

See how PVLA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow PVLA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How PVLA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for PVLAHow many large options trades hit PVLA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

PVLA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲108 buying vs 80 selling
  • ▲Held by funds +3.3 pts
  • ▲Funds holding +2
  • ▼Superinvestors: 0 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding199197+1.0%
In funds' top 10660.0%
Held by funds99.7%96.4%+3.3 pts
New / increased30 / 7835 / 89−12.9%
Reduced / sold out52 / 2843 / 19+29.0%
Put/call ratio0.112.00−94.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PVLA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

PVLA Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$850K3 buys · 2 insiders
Sold$15.6M15 sales · 4 insiders
100% of the selling was under pre-arranged trading plans.
Cluster buy: 2 insiders bought $800K between Feb 27 and Feb 27.
2025-12 sold $415K2026-01 sold $420K2026-02 bought $800K2026-02 sold $342K2026-03 bought $50K2026-03 sold $508K2026-04 sold $547K2026-05 sold $476K2026-06 sold $476K2026-07 sold $642K2026-08 sold $655K2026-09 sold $4.9M2026-10 sold $4.1M2026-11 sold $2.1MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 11Jeffrey S MartiniChief Scientific OfficerSale plan12,500$166.65$2.1M
Oct 21Kathleen GoinCOOSale plan4,313$124.58$537K
Oct 14George M JenkinsDirectorSale plan27,500$130.16$3.6M
Sep 16Kathleen GoinCOOSale plan4,302$152.24$655K
Sep 15George M JenkinsDirectorSale plan27,500$151.53$4.2M
Sep 2Christopher P KiritsyDirectorSale313$157.00$49K
Every insider buy and sale for PVLA over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See PVLA insider trades →

From SEC Form 4 filings by PVLA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PVLA is in one of them and how their past PVLA trades turned out.

PVLA in the AI portfolios
Loading…

PVLA News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PVLA in an article yet. Here's the latest on the wider market.

PVLA in the news

About Palvella Therapeutics

Palvella Therapeutics is a biopharmaceutical company based in Wayne, Pennsylvania, that is developing topical treatments for rare skin diseases and vascular malformations where no approved therapies exist. Its lead candidate, a rapamycin gel called QTORIN rapamycin, is in clinical trials for microcystic lymphatic malformations and cutaneous venous malformations. The company also has a candidate in development for disseminated superficial actinic porokeratosis. Its target customers are patients with these conditions and the physicians who treat them.

Headquarters
Wayne, PA